Anticonvulsant potency of 10 various p-isopropoxyphenylsuccinimide derivatives in the maximal electroshock-induced seizure threshold model in mice

• Autorzy: Kocharov S.L. , Panosyan H.A. , Marzeda P. , Wroblewska-Luczka P. , Kochman E. , Wlaz A. , Luszczki J.J.

Warianty tytułu

PL

Przeciwdrgawkowe działanie 10 różnych pochodnych p-izopropoksyfenylobursztynimidów w modelu progu maksymalnego wstrząsu elektrycznego u myszy

• Języki publikacji: EN

Abstrakty

EN

Background. To compare the anticonvulsant potency of 10 various p-isopropoxyphenylsuccinimide (IPPS) derivatives [i.e., IPPS (IPPS); N-(morpholinomethyl)-IPPS (MM-IPPS); N-(anilinomethyl)-IPPS (AM-IPPS); N-hydroxymethyl-IPPS (HM-IPPS); N-(p-acetylphenyl)-IPPS (AP-IPPS); N-(p-ethoxycarbonylphenylmethyl)-IPPS (ECPM-IPPS); N-(m-bromoanilinomethyl)-IPPS (BAM-IPPS); N-(o-carboxyanilinomethyl)-IPPS (o-CAMIPPS); N-(m-carboxyanilinomethyl)-IPPS (m-CAM-IPPS); N-(p-carboxyanilinomethyl)-IPPS (p-CAM-IPPS)] in the maximal electroshock-induced seizure threshold (MEST) test in mice. Material and methods. Linear regression analysis of doses of IPPS derivatives and their threshold increases in the MEST test in mice allowed to calculate TID20 values i.e., doses of the tested IPPS derivatives that elevate by 20% the seizure threshold in IPPS-treated mice over the threshold in control animals. Results. A ll t he studied IPPS derivatives (i.e., IPPS, MMIPPS, HM-IPPS, AP-IPPS, AM-IPPS, ECPM-IPPS, o-CAM-IPPS, m-CAM-IPPS, p-CAM-IPPS and BAM-IPPS) increased in a dose dependent manner the threshold for maximal electroshockinduced seizures in mice. The TID20 values in the MEST test for IPPS, AP-IPPS, AM-IPPS, BAMIPPS, o-CAM-IPPS, m-CAM-IPPS, p-CAM-IPPS, ECPM-IPPS, HM-IPPS, and MM-IPPS were 60.44 mg/kg, 86.30 mg/kg, 44.69 mg/kg, 103.34 mg/kg, 22.43 mg/kg, 52.84 mg/kg, 80.85 mg/kg, 109.75 mg/kg, 32.62 mg/kg and 53.50 mg/kg, respectively. Conclusions. The studied IPPS derivatives with respect to their anticonvulsant potency in the MEST test can be arranged as follows: o-CAM-IPPS > HM-IPPS > AM-IPPS > m-CAM-IPPS > MM-IPPS > IPPS > p-CAM-IPPS >AP-IPPS > BAM-IPPS > ECPM-IPPS.

PL

Wprowadzenie. Porównać siłę przeciwdrgawkowego działania 10 różnych pochodnych p-izopropoksyfenylobursztynimidów (IPPS) [tj. (IPPS); N-(morfolinometylo)-IPPS (MM-IPPS); N-(anilinometylo)-IPPS (AM-IPPS); N-hydroksymetylo-IPPS (HM-IPPS); N-(p-acetylofenylo)-IPPS (AP-IPPS); N-(p-etoksykarbonylofenylometylo)-IPPS (ECPM-IPPS); N-(m-bromoanilinometylo)-IPPS (BAM-IPPS); N-(o-karboksyanilinometylo)-IPPS (o-CAM-IPPS); N-(m-karboksyanilinometylo)-IPPS (m-CAM-IPPS); N-(p-karboksyanilinometylo)-IPPS (p-CAM-IPPS)] w teście progu maksymalnego wstrząsu elektrycznego (MEST) u myszy. Materiał i metody. Analiza regresji liniowej dawek pochodnych IPPS i ich wzrostów progu w teście MEST u myszy pozwoliła policzyć wartości TID20 tj. dawki badanych pochodnych IPPS, które podnoszą o 20% próg drgawkowy u myszy, którym podano IPPS, ponad próg u zwierząt kontrolnych. Wyniki. Wszystkie badane pochodne IPPS (tj. IPPS, MM-IPPS, HM-IPPS, AP-IPPS, AM-IPPS, ECPM-IPPS, o-CAM-IPPS, m-CAM-IPPS, p-CAM-IPPS and BAM-IPPS) zwiększały w sposób zależny od dawki próg maksymalnego wstrząsu elektrycznego u myszy. Wartości TID20 w teście MEST dla IPPS, AP-IPPS, AM-IPPS, BAM-IPPS, o-CAM-IPPS, m-CAM-IPPS, p-CAM-IPPS, ECPM-IPPS, HM-IPPS i MM-IPPS wynosiły odpowiednio: 60,44 mg/kg, 86,30 mg/kg, 44,69 mg/kg, 103,34 mg/kg, 22,43 mg/kg, 52,84 mg/kg, 80,85 mg/kg, 109,75 mg/kg, 32,62 mg/kg i 53,50 mg/kg. Wnioski. Badane pochodne IPPS w odniesieniu do ich siły przeciwdrgawkowego działania można uporządkować następująco: o-CAM-IPPS > HM-IPPS > AM-IPPS > m-CAM-IPPS > MM-IPPS > IPPS > p-CAM-IPPS > AP-IPPS > BAM-IPPS > ECPM-IPPS.

Słowa kluczowe

EN

anticonvulsant effect; p-isopropoxyphenylsuccinimide; electroshock; electroshock-induced seizure threshold; mice; animal model; mouse

• Wydawca: -
• Czasopismo: Health Problems of Civilization
• Rocznik: 2017
• Tom: 11
• Numer: 3
• Opis fizyczny: p.195-201,fig.,ref.

Twórcy

autor

Kocharov S.L.

• A.L. Mnjoyan’s Institute of Fine Organic Chemistry, National Academy of Sciences in Yerevan, Yerevan, Armenia

autor

Panosyan H.A.

• Molecular Structure Research Center, National Academy of Sciences in Yerevan, Yerevan, Armenia

autor

Marzeda P.

• Medical University of Lublin, Lublin, Poland

autor

Wroblewska-Luczka P.

• Institute of Rural Health in Lublin, Lublin, Poland

autor

Kochman E.

• Medical University of Lublin, Lublin, Poland

autor

Wlaz A.

• Medical University of Lublin, Lublin, Poland

autor

Luszczki J.J.

• Medical University of Lublin, Jaczewskiego 8b, 20-090 Lublin, Poland

Bibliografia

• 1. Lason W, Dudra-Jastrzebska M, Rejdak K, Czuczwar SJ. Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update. Pharmacol Rep. 2011; 63: 271-292.
• 2. Chimirri A, De Sarro A, De Sarro G, Grasso S, Trimarchi GR, Zappala M. Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]benzimidazol-1-ones. J Med Chem. 1989; 32: 93-95.
• 3. Wong MG, Defina JA, Andrews PR. Conformational analysis of clinically active anticonvulsant drugs. J Med Chem. 1986; 29: 562-572.
• 4. Chmielewska B. Anticonvulsant action of new cyclic derivatives of phenylsuccinimides. Pharmazie. 1983; 38: 872-873.
• 5. Chmielewska B. Pharmacological properties of new cyclic derivatives of phenylsuccinimide and their influence on noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, gamma-aminobutyric acid concentrations and monoaminooxidase activity in animal brains. Pharmazie. 1984; 39: 259-262.
• 6. Edafiogho IO, Scott KR, Moore JA, Farrar VA, Nicholson JM. Synthesis and anticonvulsant activity of imidooxy derivatives. J Med Chem. 1991; 34: 387-392.
• 7. Kaminski K, Obniska J. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones. Bioorg Med Chem. 2008; 16: 4921-31.
• 8. Kaminski K, Obniska J, Dybala M. Synthesis, physicochemical and anticonvulsant properties of new N-phenylamino derivatives of 2-azaspiro[4.4]nonane- and [4.5]decane-1,3-diones: part V. Eur J Med Chem. 2008; 43: 53-61.
• 9. Owoyale JA, Lahan GD, Osuide G, Edafiogho IO. Succinimides with oxyacetate side chain as potential anticonvulsant agents. J Pharm Sci. 1981; 70: 963.
• 10. Mndzhoyan OL, Avetisyan SA, Akopyan NE, Gerasimyan DA, Dzhagatspanyan IA, Pashinyan SA. Pufemide – a new USSR antiepileptic drug. Pharm Chem J. 1983; 17: 452-455.
• 11. Luszczki J, Marzęda E, Kondrat-Wróbel M, Wróbel J, Kocharov SL, Florek-Łuszczki M. Effect of N-(pethoxycarbonylphenylmethyl)-p-isopropoxyphenylsuccinimide on the anticonvulsant action of four classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. J Pre-Clin Clin Res.2014; 8: 34-37.
• 12. Luszczki JJ, Cioczek JD, Kocharov SL, Andres-Mach M, Kominek M, Zolkowska D. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Eur J Pharmacol. 2010; 648: 74-79.
• 13. Luszczki JJ, Kocharov SL, Czuczwar SJ. Effect of p-isopropoxyphenylsuccinimide monohydrate on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model. Pharmacol Rep. 2010; 62: 194-202.
• 14. Luszczki JJ, Kocharov SL, Czuczwar SJ. N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model. Neurosci Res. 2009; 64: 267-272.
• 15. Luszczki JJ, Kominek M, Florek-Luszczki M, Tchaytchian DA, Kocharov SL, Zolkowska D. Influence of N-hydroxymethyl-p-isopropoxyphenylsuccinimide on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Epilepsy Res. 2012; 100: 27-36.
• 16. Łuszczki JJ, Kominek M, Marzęda E, Durmowicz D, Florek-Łuszczki M, Kocharov SL. Influence of N-(pacetylphenyl)-p-isopropoxyphenylsuccinimide on the protective action of classical antiepileptic drugs against maximal electroshock-induced seizures in mice. Curr Issues Pharm Med Sci. 2013; 26: 76-81.
• 17. Luszczki JJ, Marzeda E, Kondrat-Wrobel MW, Pyrka D, Kocharov SL, Florek-Luszczki M. Effect of N-(mbromoanilinomethyl)-p-isopropoxyphenylsuccinimide on the anticonvulsant action of four classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Curr Issues Pharm Med Sci. 2014; 27: 76-79.
• 18. Zolkowska D, Kominek M, Florek-Luszczki M, Kocharov SL, Luszczki JJ. Effects of N-(morpholinomethyl)-p-isopropoxyphenylsuccinimide on the protective action of different classical antiepileptic drugs against maximal electroshock-induced tonic seizures in mice. Pharmacol Rep. 2013; 65: 389-398.
• 19. Swinyard EA, Brown WC, Goodman LS. Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther. 1952; 106: 319-330.
• 20. Zolkowska D, Andres-Mach M, Prisinzano TE, Baumann MH, Luszczki JJ. Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model. Psychopharmacology. 2015; 232: 2463-2479.
• 21. Swiader MJ, Paruszewski R, Luszczki JJ. Assessment of the anticonvulsant potency of various benzylamidederivatives in the mouse maximal electroshock-induced seizure threshold model. Pharmacol Rep. 2016; 68: 259-262.
• 22. Loscher W, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res. 1991; 8: 79-94.
• 23. Czapinski P, Blaszczyk B, Czuczwar SJ. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem. 2005; 5: 3-14.

Identyfikatory

DOI

10.5114/hpc.2017.70010.